Welcome to LookChem.com Sign In|Join Free

CAS

  • or

28837-77-6

Post Buying Request

28837-77-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

28837-77-6 Usage

General Description

(5-methoxy-1H-indol-2-yl)-morpholin-4-yl-methanone is a chemical compound with a complex structure, consisting of a 5-methoxy-1H-indole unit that is linked to a morpholine ring and a methanone group. (5-methoxy-1H-indol-2-yl)-morpholin-4-yl-methanone may have potential applications in the field of medicinal chemistry, as it combines the pharmacophores of indole and morpholine, which have been associated with various biological activities. The methoxy group on the indole unit and the presence of the morpholine ring suggest that this compound may have the ability to interact with various biological targets, making it a potentially interesting compound for further research and development in the pharmaceutical industry. However, further studies are needed to fully understand the properties and potential uses of this chemical.

Check Digit Verification of cas no

The CAS Registry Mumber 28837-77-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,8,3 and 7 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 28837-77:
(7*2)+(6*8)+(5*8)+(4*3)+(3*7)+(2*7)+(1*7)=156
156 % 10 = 6
So 28837-77-6 is a valid CAS Registry Number.
InChI:InChI=1/C14H16N2O3/c1-18-11-2-3-12-10(8-11)9-13(15-12)14(17)16-4-6-19-7-5-16/h2-3,8-9,15H,4-7H2,1H3

28837-77-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (5-methoxy-1H-indol-2-yl)-morpholin-4-ylmethanone

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:28837-77-6 SDS

28837-77-6Relevant articles and documents

NOVEL INDENE DERIVATIVE, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING RETINAL DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT

-

Paragraph 0137-0139, (2017/06/23)

The present invention relates to a novel indene derivative, a preparation method for the same, and a pharmaceutical composition for preventing or treating retinal disease comprising the same as an active ingredient. The novel indene derivative of the present invention, the optical isomer of the same, or the pharmaceutically acceptable salts of the same have excellent inhibitory efficiency of receptor-interacting serine/threonine-protein kinase 1 (RIPK1). Therefore, the composition containing the same as an active ingredient can be effectively used as a pharmaceutical composition for preventing or treating retinal disease exemplified by retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardts disease, Usher syndrome, choroideremia, rod-cone or cone-rod dystrophy, ciliopathy, mitochondrial disorders, progressive retinal atrophy, degenerative retinal diseases, age-related macular degeneration (AMD), wet AMD, dry AMD, geographical atrophy, inherited or acquired macular degeneration, retinal photoreceptor diseases, retinal pigment epithelial diseases, diabetic retinopathy, cystic macular edema, uveitis, retinal detachment, traumatic retinal injury, iatrogenic retinal injury, macular holes, macular capillarectasia, ganglion cell diseases, optic nerve diseases, glaucoma, optic neuropathy, ischemic retinal diseases, retinopathy of prematurity, occlusion of retinal vessels, inherited macroaneurysm, retinal vascular diseases, ophthalmic vascular diseases, glaucomatous retinal neurodegeneration, ischemic optic neuropathy and the like.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 28837-77-6